Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
OR | IC 95% | p | OR | IC 95% | p | |
DIC | 3.32 | 2.07–5.33 | < 0.001 | 2.82 | 1.53–5.20 | 0.001 |
Male sex | 0.89 | 0.55–1.42 | 0.62 | – | – | – |
Age, (per 1-year increment) | 1.01 | 0.99–1.02 | 0.364 | 0.97 | 0.95–1 | 0.048 |
SAPS II (per 1pt increment) | 1.06 | 1.04–1.08 | < 0.001 | 1.06 | 1.04–1.07 | < 0.001 |
SOFA (per 1pt increment) | 1.44 | 1.31–1.58 | < 0.001 | – | – | – |
Chronic hypertension | 2.05 | 1.26–3.32 | 0.004 | 2.16 | 1.11–4.20 | 0.023 |
Diabetes | 1.57 | 0.97–2.56 | 0.068 | 1.36 | 0.73–2.54 | 0.337 |
Chronic heart failure | 1.21 | 0.50–2.95 | 0.674 | – | – | – |
CKD | 1.67 | 0.90–3.11 | 0.106 | 1.70 | 0.74–3.90 | 0.208 |
Liver cirrhosis | 4.31 | 1.41–13.18 | 0.01 | 2.01 | 0.50–7.89 | 0.325 |
Cancer | 0.64 | 0.33–1.21 | 0.168 | 0.55 | 0.25–1.24 | 0.15 |
COPD | 0.99 | 0.56–1.78 | 0.986 | – | – | – |
Source of infection | ||||||
Lung | 0.84 | 0.52–1.36 | 0.474 | – | – | – |
Abdominal | 1.74 | 0.95–3.18 | 0.071 | 1.58 | 0.76–3.31 | 0.221 |
Urinary tract | 0.83 | 0.47–1.48 | 0.526 | – | – | – |
Bloodstream infection | 0.71 | 0.41–1.21 | 0.208 | – | – | – |
Nosocomial infection | 0.76 | 0.33–1.76 | 0.525 | – | – | – |
Immunosuppression | 1.14 | 0.56–2.31 | 0.723 | – | – | – |
Cocci gram positive | 0.59 | 0.36–0.97 | 0.037 | 0.53 | 0.29–0.97 | 0.04 |
Bacillus gram negative | 1.37 | 0.87–2.16 | 0.173 | 1.15 | 0.62–1.96 | 0.747 |
Organ-support at inclusion | ||||||
Epinephrine | 4.77 | 2.31–9.83 | < 0.001 | 1.32 | 0.52–3.36 | 0.556 |
Dobutamine | 1.6 | 0.92–2.79 | 0.097 | 1.12 | 0.55–2.31 | 0.75 |
Norepinephrine > 1 µg/kg/min at day 1 | 3.75 | 2.31–6.08 | < 0.001 | 0.57 | 0.31–1.07 | 0.079 |
Fluid before inclusion > 1L | 2.31 | 0.73–7.35 | 0.155 | 0.67 | 0.37–1.22 | 0.193 |
Nephrotoxic drugs, yes | 0.73 | 0.26–2.07 | 0.557 | – | – | – |
Nephrotoxic drugs | 1.09 | 0.91–1.33 | 0.336 | 1.02 | 0.80–1.30 | 0.871 |